 |
PDBsum entry 6b7c
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Crystal structure of e.Coli phosphopantetheine adenylyltransferase (ppat/coad) in complex with n-((1,3-dimethyl-1h-pyrazol-5-yl)methyl)- 5-methyl-1h-imidazo[4,5-b]pyridin-2-amine
|
|
Structure:
|
 |
Phosphopantetheine adenylyltransferase. Chain: a, b. Synonym: dephospho-coa pyrophosphorylase,pantetheine-phosphate adenylyltransferase,ppat. Engineered: yes
|
|
Source:
|
 |
Escherichia coli (strain k12). Organism_taxid: 83333. Strain: k12. Gene: coad, kdtb, yica, b3634, jw3609. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
1.56Å
|
R-factor:
|
0.175
|
R-free:
|
0.199
|
|
|
Authors:
|
 |
A.W.Proudfoot,D.Bussiere,A.Lingel
|
|
Key ref:
|
 |
A.Proudfoot
et al.
(2017).
High-Confidence Protein-Ligand Complex Modeling by NMR-Guided Docking Enables Early Hit Optimization.
J Am Chem Soc,
139,
17824-17833.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
03-Oct-17
|
Release date:
|
27-Dec-17
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P0A6I6
(COAD_ECOLI) -
Phosphopantetheine adenylyltransferase from Escherichia coli (strain K12)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
159 a.a.
159 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.7.3
- pantetheine-phosphate adenylyltransferase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
Coenzyme A Biosynthesis (late stages)
|
 |
 |
 |
 |
 |
Reaction:
|
 |
(R)-4'-phosphopantetheine + ATP + H+ = 3'-dephospho-CoA + diphosphate
|
 |
 |
 |
 |
 |
(R)-4'-phosphopantetheine
|
+
|
ATP
|
+
|
H(+)
|
=
|
3'-dephospho-CoA
|
+
|
diphosphate
Bound ligand (Het Group name = )
corresponds exactly
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Am Chem Soc
139:17824-17833
(2017)
|
|
PubMed id:
|
|
|
|
|
| |
|
High-Confidence Protein-Ligand Complex Modeling by NMR-Guided Docking Enables Early Hit Optimization.
|
|
A.Proudfoot,
D.E.Bussiere,
A.Lingel.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Structure-based drug design is an integral part of modern day drug discovery and
requires detailed structural characterization of protein-ligand interactions,
which is most commonly performed by X-ray crystallography. However, the success
rate of generating these costructures is often variable, in particular when
working with dynamic proteins or weakly binding ligands. As a result, structural
information is not routinely obtained in these scenarios, and ligand
optimization is challenging or not pursued at all, representing a substantial
limitation in chemical scaffolds and diversity. To overcome this impediment, we
have developed a robust NMR restraint guided docking protocol to generate
high-quality models of protein-ligand complexes. By combining the use of highly
methyl-labeled protein with experimentally determined intermolecular distances,
a comprehensive set of protein-ligand distances is generated which then drives
the docking process and enables the determination of the correct ligand
conformation in the bound state. For the first time, the utility and performance
of such a method is fully demonstrated by employing the generated models for the
successful, prospective optimization of crystallographically intractable
fragment hits into more potent binders.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |